A panel of experts from the U.S. Food and Drug Administration confirms safety suspicions against oxymorphone hydrochloride, otherwise known as OPANA ER, which is a prescription opioid by Endo International Plc.
A panel of experts from the U.S. Food and Drug Administration confirms safety suspicions against oxymorphone hydrochloride, otherwise known as OPANA ER, which is a prescription opioid by Endo International Plc.